Trials / Conditions / Resectable
Resectable
3 registered clinical trials studyying Resectable — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery f NCT06923475 | Amsterdam UMC, location VUmc | Phase 2 / Phase 3 |
| Completed | Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer NCT03794544 | MedImmune LLC | Phase 2 |
| Recruiting | Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tiss NCT03805022 | Institut Bergonié | Phase 3 |